The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Oncology Radiopharmaceutical Market Research Report 2024

Global Oncology Radiopharmaceutical Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1742600

No of Pages : 95

Ask Your Query

Synopsis
Global Oncology Radiopharmaceutical market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oncology Radiopharmaceutical market research.

Key manufacturers engaged in the Oncology Radiopharmaceutical industry include Novartis, Chimeric Therapeutics Limited, Fusion Pharma, Lantheus Medical lmaging, Inc., NanoMab, NuView Life Sciences., PentixaPharm GmbHPrecirix, RadioMedix and RayzeBio, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Oncology Radiopharmaceutical were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Oncology Radiopharmaceutical market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oncology Radiopharmaceutical market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Novartis
  • Chimeric Therapeutics Limited
  • Fusion Pharma
  • Lantheus Medical lmaging, Inc.
  • NanoMab
  • NuView Life Sciences.
  • PentixaPharm GmbHPrecirix
  • RadioMedix
  • RayzeBio
  • Telix Pharmaceuticals Limited
  • Theragnostics Ltd
  • Vect-Horus

Segment by Type

  • Oral Drugs
  • Intravenous Drugs
  • Other

Segment by Application

  • Hospitals and Clinics
  • Pharmaceutical Company
  • Research Center
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Oncology Radiopharmaceutical report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Oncology Radiopharmaceutical Market Overview
1.1 Product Overview and Scope of Oncology Radiopharmaceutical
1.2 Oncology Radiopharmaceutical Segment by Type
1.2.1 Global Oncology Radiopharmaceutical Market Value Comparison by Type (2023-2029)
1.2.2 Oral Drugs
1.2.3 Intravenous Drugs
1.2.4 Other
1.3 Oncology Radiopharmaceutical Segment by Application
1.3.1 Global Oncology Radiopharmaceutical Market Value by Application: (2023-2029)
1.3.2 Hospitals and Clinics
1.3.3 Pharmaceutical Company
1.3.4 Research Center
1.3.5 Other
1.4 Global Oncology Radiopharmaceutical Market Size Estimates and Forecasts
1.4.1 Global Oncology Radiopharmaceutical Revenue 2018-2029
1.4.2 Global Oncology Radiopharmaceutical Sales 2018-2029
1.4.3 Global Oncology Radiopharmaceutical Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oncology Radiopharmaceutical Market Competition by Manufacturers
2.1 Global Oncology Radiopharmaceutical Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oncology Radiopharmaceutical Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oncology Radiopharmaceutical Average Price by Manufacturers (2018-2023)
2.4 Global Oncology Radiopharmaceutical Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oncology Radiopharmaceutical, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oncology Radiopharmaceutical, Product Type & Application
2.7 Oncology Radiopharmaceutical Market Competitive Situation and Trends
2.7.1 Oncology Radiopharmaceutical Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oncology Radiopharmaceutical Players Market Share by Revenue
2.7.3 Global Oncology Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oncology Radiopharmaceutical Retrospective Market Scenario by Region
3.1 Global Oncology Radiopharmaceutical Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oncology Radiopharmaceutical Global Oncology Radiopharmaceutical Sales by Region: 2018-2029
3.2.1 Global Oncology Radiopharmaceutical Sales by Region: 2018-2023
3.2.2 Global Oncology Radiopharmaceutical Sales by Region: 2024-2029
3.3 Global Oncology Radiopharmaceutical Global Oncology Radiopharmaceutical Revenue by Region: 2018-2029
3.3.1 Global Oncology Radiopharmaceutical Revenue by Region: 2018-2023
3.3.2 Global Oncology Radiopharmaceutical Revenue by Region: 2024-2029
3.4 North America Oncology Radiopharmaceutical Market Facts & Figures by Country
3.4.1 North America Oncology Radiopharmaceutical Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oncology Radiopharmaceutical Sales by Country (2018-2029)
3.4.3 North America Oncology Radiopharmaceutical Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oncology Radiopharmaceutical Market Facts & Figures by Country
3.5.1 Europe Oncology Radiopharmaceutical Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oncology Radiopharmaceutical Sales by Country (2018-2029)
3.5.3 Europe Oncology Radiopharmaceutical Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oncology Radiopharmaceutical Market Facts & Figures by Country
3.6.1 Asia Pacific Oncology Radiopharmaceutical Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oncology Radiopharmaceutical Sales by Country (2018-2029)
3.6.3 Asia Pacific Oncology Radiopharmaceutical Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oncology Radiopharmaceutical Market Facts & Figures by Country
3.7.1 Latin America Oncology Radiopharmaceutical Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oncology Radiopharmaceutical Sales by Country (2018-2029)
3.7.3 Latin America Oncology Radiopharmaceutical Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oncology Radiopharmaceutical Market Facts & Figures by Country
3.8.1 Middle East and Africa Oncology Radiopharmaceutical Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oncology Radiopharmaceutical Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oncology Radiopharmaceutical Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oncology Radiopharmaceutical Sales by Type (2018-2029)
4.1.1 Global Oncology Radiopharmaceutical Sales by Type (2018-2023)
4.1.2 Global Oncology Radiopharmaceutical Sales by Type (2024-2029)
4.1.3 Global Oncology Radiopharmaceutical Sales Market Share by Type (2018-2029)
4.2 Global Oncology Radiopharmaceutical Revenue by Type (2018-2029)
4.2.1 Global Oncology Radiopharmaceutical Revenue by Type (2018-2023)
4.2.2 Global Oncology Radiopharmaceutical Revenue by Type (2024-2029)
4.2.3 Global Oncology Radiopharmaceutical Revenue Market Share by Type (2018-2029)
4.3 Global Oncology Radiopharmaceutical Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oncology Radiopharmaceutical Sales by Application (2018-2029)
5.1.1 Global Oncology Radiopharmaceutical Sales by Application (2018-2023)
5.1.2 Global Oncology Radiopharmaceutical Sales by Application (2024-2029)
5.1.3 Global Oncology Radiopharmaceutical Sales Market Share by Application (2018-2029)
5.2 Global Oncology Radiopharmaceutical Revenue by Application (2018-2029)
5.2.1 Global Oncology Radiopharmaceutical Revenue by Application (2018-2023)
5.2.2 Global Oncology Radiopharmaceutical Revenue by Application (2024-2029)
5.2.3 Global Oncology Radiopharmaceutical Revenue Market Share by Application (2018-2029)
5.3 Global Oncology Radiopharmaceutical Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novartis Oncology Radiopharmaceutical Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Chimeric Therapeutics Limited
6.2.1 Chimeric Therapeutics Limited Corporation Information
6.2.2 Chimeric Therapeutics Limited Description and Business Overview
6.2.3 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Portfolio
6.2.5 Chimeric Therapeutics Limited Recent Developments/Updates
6.3 Fusion Pharma
6.3.1 Fusion Pharma Corporation Information
6.3.2 Fusion Pharma Description and Business Overview
6.3.3 Fusion Pharma Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fusion Pharma Oncology Radiopharmaceutical Product Portfolio
6.3.5 Fusion Pharma Recent Developments/Updates
6.4 Lantheus Medical lmaging, Inc.
6.4.1 Lantheus Medical lmaging, Inc. Corporation Information
6.4.2 Lantheus Medical lmaging, Inc. Description and Business Overview
6.4.3 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Portfolio
6.4.5 Lantheus Medical lmaging, Inc. Recent Developments/Updates
6.5 NanoMab
6.5.1 NanoMab Corporation Information
6.5.2 NanoMab Description and Business Overview
6.5.3 NanoMab Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
6.5.4 NanoMab Oncology Radiopharmaceutical Product Portfolio
6.5.5 NanoMab Recent Developments/Updates
6.6 NuView Life Sciences.
6.6.1 NuView Life Sciences. Corporation Information
6.6.2 NuView Life Sciences. Description and Business Overview
6.6.3 NuView Life Sciences. Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
6.6.4 NuView Life Sciences. Oncology Radiopharmaceutical Product Portfolio
6.6.5 NuView Life Sciences. Recent Developments/Updates
6.7 PentixaPharm GmbHPrecirix
6.6.1 PentixaPharm GmbHPrecirix Corporation Information
6.6.2 PentixaPharm GmbHPrecirix Description and Business Overview
6.6.3 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
6.4.4 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Portfolio
6.7.5 PentixaPharm GmbHPrecirix Recent Developments/Updates
6.8 RadioMedix
6.8.1 RadioMedix Corporation Information
6.8.2 RadioMedix Description and Business Overview
6.8.3 RadioMedix Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
6.8.4 RadioMedix Oncology Radiopharmaceutical Product Portfolio
6.8.5 RadioMedix Recent Developments/Updates
6.9 RayzeBio
6.9.1 RayzeBio Corporation Information
6.9.2 RayzeBio Description and Business Overview
6.9.3 RayzeBio Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
6.9.4 RayzeBio Oncology Radiopharmaceutical Product Portfolio
6.9.5 RayzeBio Recent Developments/Updates
6.10 Telix Pharmaceuticals Limited
6.10.1 Telix Pharmaceuticals Limited Corporation Information
6.10.2 Telix Pharmaceuticals Limited Description and Business Overview
6.10.3 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Portfolio
6.10.5 Telix Pharmaceuticals Limited Recent Developments/Updates
6.11 Theragnostics Ltd
6.11.1 Theragnostics Ltd Corporation Information
6.11.2 Theragnostics Ltd Oncology Radiopharmaceutical Description and Business Overview
6.11.3 Theragnostics Ltd Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Theragnostics Ltd Oncology Radiopharmaceutical Product Portfolio
6.11.5 Theragnostics Ltd Recent Developments/Updates
6.12 Vect-Horus
6.12.1 Vect-Horus Corporation Information
6.12.2 Vect-Horus Oncology Radiopharmaceutical Description and Business Overview
6.12.3 Vect-Horus Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Vect-Horus Oncology Radiopharmaceutical Product Portfolio
6.12.5 Vect-Horus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oncology Radiopharmaceutical Industry Chain Analysis
7.2 Oncology Radiopharmaceutical Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oncology Radiopharmaceutical Production Mode & Process
7.4 Oncology Radiopharmaceutical Sales and Marketing
7.4.1 Oncology Radiopharmaceutical Sales Channels
7.4.2 Oncology Radiopharmaceutical Distributors
7.5 Oncology Radiopharmaceutical Customers
8 Oncology Radiopharmaceutical Market Dynamics
8.1 Oncology Radiopharmaceutical Industry Trends
8.2 Oncology Radiopharmaceutical Market Drivers
8.3 Oncology Radiopharmaceutical Market Challenges
8.4 Oncology Radiopharmaceutical Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock